From GlobeNewswire: 2025-01-29 01:00:00

Borregaard reported operating revenues of NOK 1,744 million in Q4 2024, with EBITDA reaching NOK 398 million. BioSolutions saw an increase in results, while BioMaterials remained stable and Fine Chemicals decreased. Sales growth drove BioSolutions’ strong performance, offset by higher wood costs in BioMaterials and lower deliveries in Fine Chemicals.

Other income and expenses were NOK -30 million in Q4 2024, primarily for soil remediation at the Sarpsborg site. Profit before tax reached NOK 170 million, with earnings per share at NOK 1.30. For the full year 2024, operating revenues increased to NOK 7,617 million, and EBITDA hit an all-time high of NOK 1,874 million.

President and CEO Per A. Sørlie expressed satisfaction with the record-breaking 2024 results, attributing them to the company’s specialization strategy’s resilience in a challenging economic landscape. Key contacts for further information include Director Investor Relations Knut-Harald Bakke and Director Communications Tone Horvei Bredal. Borregaard’s performance data are in compliance with relevant market regulations.

This update was released by Lotte Kvinlaug, Investor Relations Officer at Borregaard ASA, on January 29, 2025, at 07:00 CET.



Read more at GlobeNewswire:: EBITDA1 of NOK 398 million in the 4th